ATLANTA, GA—More than a decade after the TACT trial reported an astonishing reduction in cardiovascular events post-MI with heavy metal chelation in a subset of diabetic patients, the TACT2 trial, ...

ATLANTA -- Chelation to remove lead and other heavy metals didn't improve outcomes for type 2 diabetes patients after myocardial infarction (MI), the TACT2 trial showed. Cumulative incidence of time ...

Atherosclerotic cardiovascular disease (CVD) is highly prevalent and, despite therapeutic advances, remains a leading cause of morbidity and mortality. Many patients with CVD seek additional ...

A government-funded study seems to show a benefit for heart-attack patients who receive a controversial treatment called chelation, an arduous process that is used by some alternative medicine ...

Final results of the troubled NIH-sponsored TACT trial testing chelation therapy for coronary disease have now been published in JAMA. Last November, when the preliminary results were presented at the ...

If you were to believe everything you heard about chelation therapy, you might think it’s something of a cure-all. Satisfied patients describe miraculous improvements in conditions such as asthma and ...

When determining the types of patients to be recruited for the trial, there was concern that the benefits of chelation might not be easily discerned if the participants were too healthy; patients who ...

Recently, there has been a growing interest in EDTA supplements due to the possible health benefits they provide. Ethylenediaminetetraacetic acid (EDTA), a chelating agent, bonds with heavy metals and ...

PNEUMONOCONIOSIS associated with heavy-metal inhalation has long resisted most forms of therapy. The development of chelating agents offers a new approach to this problem. This report concerns our ...